Mary V. Relling
Genetics · 2001–2018
A researcher in the Science corpus: 13 papers; trusts 3 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 46 citations into it; #2,727 of 6,854 by trust here, #2,654 by citations
- Oncology — 13 citations into it
- Pharmacology — 11 citations into it; #289 of 1,112 by trust here, #306 by citations
Whom Mary V. Relling trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mary V. Relling overall
Papers from Mary V. Relling's perspective
Ordered by how strongly the researchers Mary V. Relling trusts endorse each paper. Same corpus, a different order for every researcher.
- Analysis of protein-coding genetic variation in 60,706 humans
- Genetic Structure of Human Populations
- Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular…
- Using high-resolution variant frequencies to empower clinical genome interpretation (Genetics in Medicine)
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (Nature)
- The importance of race and ethnic background in biomedical research and clinical practice. (New England Journal of Medicine)
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma (Nature Genetics)
- Measuring the activity of protein variants on a large scale using deep mutational scanning
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. (Blood)
- Inheritance and drug response. (New England Journal of Medicine)
Their papers
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia (2007) — 1,888 citations
- Moving towards individualized medicine with pharmacogenomics (2004) — 776 citations
- Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing (2018) — 402 citations
- THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA (2017) — 810 citations
- Pharmacogenomics in the clinic (2015) — 790 citations
- Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. (2015) — 870 citations
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia (2014) — 1,229 citations
- Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia (2009) — 1,317 citations
- Treating childhood acute lymphoblastic leukemia without cranial irradiation. (2009) — 1,165 citations
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros (2008) — 1,112 citations
- Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. (2004) — 623 citations
- Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. (2002) — 1,999 citations
- Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression (2001) — 2,260 citations